CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
J Pharmacol Exp Ther. 2017 Oct;363(1):35-44. doi: 10.1124/jpet.117.242735. Epub 2017 Aug 2.
J Pharmacol Exp Ther. 2017.
PMID: 28768817